MedTrace Logo

Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients

NCT01204281 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2012-11-27

No results posted yet for this study

Summary

To evaluate the effectiveness of high assistance proportional assist ventilation (PAV+) (objective 80% gain) as main ventilatory support in early stage of critically ill patients in comparison with standard volume-assist control ventilation (ACV).

Conditions

Interventions

OTHER

Mechanical ventilation mode (PAV+ vs. ACV)

Compare two ventilatory modes in the acute phase of illness

Sponsors & Collaborators

  • Medtronic - MITG

    collaborator INDUSTRY

  • Althaia Xarxa Assistencial Universitària de Manresa

    lead OTHER

Principal Investigators

  • Rafael Fernandez, M.D. · Althaia Xarxa Assistencial Universitària de Manresa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01204281 on ClinicalTrials.gov